Former Senior Vice President & Chief Commercial Officer · Bioventus Inc. (BVS)

John Nosenzo

A named executive officer of Bioventus in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$2,276,548

Salary $416,859Stock awards $499,994Bonus $260,000

FY2021: $3,807,016

3rd of 4 named executive officers at Bioventus by FY2022 total.

4 named officers on file for Bioventus, FY2022

John Nosenzo’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bioventus’s whole pay program stands against its peers

  • Bioventus’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BVS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get John Nosenzo’s full pay file as a PDF — free

More than this page: up to 10 years of John’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

John Nosenzo compensation by year

Bioventus Summary Compensation Table · all 3 fiscal years held
In US dollars, as Bioventus reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$504,893$534,302$416,859
Bonus$21,778$260,000$260,000
Stock awards$0$1,640,877$499,994
Option awards$0$716,562$499,894
Non-equity incentive$357,646$631,005$0
Pension and deferred compensation$0$0$0
All other$22,959$24,270$599,801
Total$907,276$3,807,016$2,276,548

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bioventus Inc. DEF 14A filed April 27, 2023, accession 0001193125-23-120232, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bioventus Inc. filed document, accession 0001193125-23-120232. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$907K
$3.8M
$2.3M
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Bioventus’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Kenneth RealiFormer Chief Executive Officer$4,395,233
Mark SingletonSenior Vice President & Chief Financial Officer$2,462,453
John Nosenzo · this pageFormer Senior Vice President & Chief Commercial Officer$2,276,548
Alessandra PavesioFormer Senior Vice President & Chief Science Officer$2,044,416

The full Bioventus compensation record

free company brief

This page is one person within Bioventus's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bioventus's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Nosenzo's compensation dossier · One-time report. No refunds.